Axatilimab + CAR-T for High-Risk Lymphoma

Clinical trial NCT07638982 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07638982
Sponsor: Northside Hospital, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma (DLBCL)Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma High-grade B-cell Lymphoma (HGBCL)High-Grade B-Cell Lymphoma, Nos PMBCL Follicular Grade 3 Lymphoma

Start date: 2026-10-31
Primary completion: 2028-12-31
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.